Experimental prostate cancer treatments halted in early trial
NCT ID NCT04631601
Summary
This study tested several experimental drug combinations for men with advanced prostate cancer that had spread and stopped responding to standard hormone treatments. The trial aimed to find safe doses and see if these new approaches could help control the cancer. It was terminated early and enrolled 65 participants who had not responded to previous therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Akademiska sjukhuset
Uppsala, 75185, Sweden
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Karolinska Universitetssjukhuset Solna
Stockholm, 171 76, Sweden
-
Norton Cancer Institute
Louisville, Kentucky, 40207, United States
-
Rigshospitalet
København Ø, 2100, Denmark
-
Royal Marsden Hospital
Sutton, SM2 5PT, United Kingdom
-
Skanes universitetssjukhus
Lund, 221 85, Sweden
-
St Vincents Hospital Sydney
Darlinghurst, New South Wales, 2010, Australia
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of California San Francisco Mission Bay Campus
San Francisco, California, 94158, United States
-
University of California at Irvine Medical Center
Orange, California, 92868, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.